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ampicillin [3], this might contribute to the therapeutic
action of the two antibiotics in human listeriosis.
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Response to a Letter from W H Heizmann (Clin Microbiol
Irifect 1997; 3: 133-4)
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Heizmann [1] is to be congratulated for his excellent
approach to antibiotic utilization which should enhance
appropriate and judicious use of antibiotics in his
hospital. Such individually structured regimens are
really the 'gold standard' to which everyone should
aspire. Unfortunately, many hospitals are not fortunate
enough to have the expertise required for this approach
nor do they have sufficient staff to devote to this
pursuit. Thus, alternative approaches for the less than
optimally staffed hospital need to be considered. One
alternative (of many possibilities) would be cycling.
Several items concerning the cycling scheme we
proposed [2] need clarification. First, empiric therapy
does not refer to a set regimen applied blindly. Rather,
it refers to therapy administered during a finite (and
hopefully short) time interval during which the precise
etiology of the infection is unknown. This therapy
is still selected utilizing information relating to those
five factors listed by Heizmann as components of
'calculated chemotherapy' [1). For most patients in a
specialized unit of the hospital, since they share similar
risk factors for infection and the same hospital
microbial environment, the empiric regimen would be
similar, but not always identical. Secondly, to predict
that multidrug resistant pathogens will emerge in an
area of the hospital using a cycling scheme is to ignore
the basic concept of the cycle. The cycle is to be
changed prior to the time that resistance to drugs in the
current phase of the cycle appears. If resistance appears,
then the time of the phase of use of those drugs in the
cycle needs to be shortened when their phase comes
around again. If resistance has not disappeared when
their phase comes around again, the drugs should be
dropped from the cycle until resistance disappears and
alternative drugs should be inserted into the cycle.
Thirdly, staffconfusion as to which portion of the cycle
is the current regimen should not be a problem.
Virtually every hospital now has individuals who
monitor drug utilization. This monitoring ranges from
formulary issues, to therapeutic drug monitoring, to
potential drug interactions. Thus, the mechanism is
already in place for monitoring antibiotics used in a
cycling scheme.
As we noted, any approach to therapy that reduces
the total amount of a specific antibiotic utilized in a
given environment should reduce resistance to that
drug [2]. Cycling is only one of a large number of
possibilities. Heizmann [1] has suggested a second
excellent approach. Each hospital needs to assess
antibiotic utilization and define what approach is most
appropriate and practical for its special care units.
Careful, prospective trials of various approaches should
be encouraged. It is high time that we try to prevent
resistance, rather than try to deal with it once it has
been encountered. We hope to be more successful with
the former than we have been with the latter.
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